Intermediate-Dose Enoxaparin After Cardiac Ablation Procedures
Journal Title: Journal of Hypertension and Cardiology - Year 2014, Vol 1, Issue 3
Abstract
Objective: Ablation of foci within the atria has been shown to resolve symptoms of atrial fibrillation and atrial flutter. However, no standard has been established for anticoagulation after the procedure. Enoxaparin has been well described in the literature as a means to provide anticoagulation after ablation procedures. The only enoxaparin doses previously studied were 0.5 mg/kg and 1 mg/kg, both given every 12 hours. The purpose of the study was to compare the incidence of a major bleed or vascular complication in patients who received enoxaparin doses between 0.5 mg/kg and 1 mg/kg every 12 hours with patients who received either 0.5 mg/kg or 1 mg/kg every 12 hours. Methods: This IRB-approved, single-center, retrospective, cohort study included subjects greater than 18 years of age who received an atrial fibrillation or atrial flutter ablation procedure and at least one dose of enoxaparin post-ablation. Results: There were 119 subjects who satisfied the inclusion criteria. The primary outcome, incidence of major bleeding or vascular complication, did not demonstrate a statistically significant difference between groups (p = 0.92). The incidences were 4.8% with enoxaparin ≥ 1 mg/kg, 3% with enoxaparin between 0.5 mg/kg and 1 mg/kg, and 3.2% with enoxaparin ≤ 0.5 mg/kg. No subject experienced an ischemic stroke or transient ischemic attack within 28 days of a cardiac ablation procedure. Conclusion: Significant increases in major bleeding or vascular complications may not exist with an intermediate dose of enoxaparin provided after a cardiac ablation procedure.
Authors and Affiliations
Drayton A. Hammond, Christina E. DeRemer, David M. Killough, Adam E. Berman
Keywords
Related Articles
- EP ID EP279572
- DOI 10.14302/issn.2329-9487.jhc-13-313
- Views 118
- Downloads 0
Factors Associated with Uncontrolled High Blood Pressure amongst patients with Hypertension at Harare Central Hospital in Zimbabwe
Background: Hypertension is a public health problem with high mortality and morbidity globally. A rapid assessment of hypertensive patients at Harare Central Hospital Outpatients Department (OPD) in June 2013 revealed t...
Localization of Angina Related Artery by Admission ECG in Unstable Angina and NSTEMI Patients
Objective: To find out the diagnostic accuracy of admission ECG against coronary angiography (CAG) to predict the ARA in patients with USAP /NSTEMI. Background: In USAP even though multiple active plaques are documented...
Factors Affecting the Longevity of Femoropopliteal Bypasses
--
MicroRNAs: As A Novel Potential Tool for Diagnosis, Prognosis, and Therapeutic Agents in Hypertension.
The aim of this review is to compile our understanding of microRNA (miRNA) and its significance in Hypertension (HTN) pathophysiology. The wide spectrum of health disparity is one of the reasons for the dominance of HTN...
Transient Left Bundle Branch Block During the Recovery Period of a Stress Test
Exercise-dependent complete left bundle branch block is a rare entity.We present a case in which this phenomenon was demonstrated during the recovery period of a stress test. To the best of our knowledge such an observat...